World implantable cardioverter defibrillator (ICD) market set to top $1 billion by 1998
This article was originally published in Clinica
The world ICD market is set to exceed $1,100 million by the year 1998, predict US analysts at Morgan Stanley. The figure is significantly higher than earlier estimates following encouraging results of the Multicentre Automatic Defibrillator Implantation Trial (MADIT). The current ICD market is estimated at around $500-650 million.
You may also be interested in...
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.